Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GT Biopharma, Inc.GTBP · Entity 7878 | Director · CEO · 10% owner | June 02, 2020 | June 04, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GT Biopharma, Inc.
Report date June 02, 2020 · Filed June 04, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| common stockSEC Table I · non-derivative | Direct | 6,500,000 |
Reported balance
After 2020-06-02 transaction · row 1
1 source rowRow 1 · 2020-06-02 · Sale · Disposed 4,234,320 · Balance 6,500,000 F1: The disposal of the 4,234,320 shares was made to satisfy obligations pursuant to the terms of a Stock Pledge Agreement signed on August 1, 2018. |
Filing footnotes · ownership attribution and instrument terms
F1: The disposal of the 4,234,320 shares was made to satisfy obligations pursuant to the terms of a Stock Pledge Agreement signed on August 1, 2018.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 02, 2020 Filed Jun 4, 2020 21:15 UTC | GT Biopharma, Inc. GTBP · Entity 7878 | Salecommon stock | 4,234,320 | $0.00 | $4,234.32 |
DisclosureSEC source: 0000939798-20-000007 · primary_doc.xml · nonDerivative · entry 1 Cataldo Tony · CIK 0001450565 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,500,000 F1 · shares: The disposal of the 4,234,320 shares was made to satisfy obligations pursuant to the terms of a Stock Pledge Agreement signed on August 1, 2018. Read SEC document |
| August 14, 2019 Filed Aug 16, 2019 20:57 UTC | GT Biopharma, Inc. GTBP · Entity 7878 | Grantcommon stock | 7,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000939798-19-000031 · primary_doc.xml · nonDerivative · entry 1 Cataldo Tony · CIK 0001450565 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,734,320 Read SEC document |
| February 06, 2019 Filed Feb 13, 2019 16:22 UTC | GT Biopharma, Inc. GTBP · Entity 7878 | Salecommon stock | 800,000 | $0.00 | $800.00 |
DisclosureSEC source: 0000939798-19-000005 · primary_doc.xml · nonDerivative · entry 1 Cataldo Tony · CIK 0001450565 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,029,600 F1 · shares: This a stock pledge for nominal consideration in a private transaction for a personal family matter. Read SEC document |
| November 02, 2017 Filed Dec 2, 2017 00:12 UTC | GT Biopharma, Inc. GTBP · Entity 7878 | Giftcommon stock | 3,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000939798-17-000102 · primary_doc.xml · nonDerivative · entry 4 Cataldo Tony · CIK 0001450565 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,843,029 Read SEC document |
| November 02, 2017 Filed Dec 2, 2017 00:12 UTC | GT Biopharma, Inc. GTBP · Entity 7878 | Giftcommon stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000939798-17-000102 · primary_doc.xml · nonDerivative · entry 3 Cataldo Tony · CIK 0001450565 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,843,029 Read SEC document |
| November 02, 2017 Filed Dec 2, 2017 00:12 UTC | GT Biopharma, Inc. GTBP · Entity 7878 | Giftcommon stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000939798-17-000102 · primary_doc.xml · nonDerivative · entry 2 Cataldo Tony · CIK 0001450565 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,943,029 Read SEC document |
| September 01, 2017 Filed Dec 2, 2017 00:12 UTC | GT Biopharma, Inc. GTBP · Entity 7878 | Grantcommon stock | 5,129,660 | $0.00 | $0.00 |
DisclosureSEC source: 0000939798-17-000102 · primary_doc.xml · nonDerivative · entry 1 Cataldo Tony · CIK 0001450565 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,143,029 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.